MPOX (MONKEYPOX)
Clinical trials for MPOX (MONKEYPOX) explained in plain language.
Never miss a new study
Get alerted when new MPOX (MONKEYPOX) trials appear
Sign up with your email to follow new studies for MPOX (MONKEYPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mpox vaccine trial targets HIV-Positive adults in DRC
⭐️ VACCINE ⭐️ OngoingThis study tests whether the MVA-BN vaccine can safely protect people living with HIV from mpox. About 600 adults in Kinshasa, DRC, will receive two doses of the vaccine, 28 days apart. Researchers will check how well the vaccine triggers an immune response and monitor for side e…
Matched conditions: MPOX (MONKEYPOX)
Phase: PHASE2 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:07 UTC
-
Mpox vaccine trial for infants could protect thousands in outbreak zone
⭐️ VACCINE ⭐️ OngoingThis study tests the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo, a high-risk area. Half receive a full dose and half a half dose, both given as two shots 28 days apart. The goal is to see if the vaccine is safe and …
Matched conditions: MPOX (MONKEYPOX)
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:53 UTC